US SB3116 | 2019-2020 | 116th Congress

Status

Spectrum: Bipartisan Bill
Status: Introduced on December 19 2019 - 25% progression, died in committee
Action: 2019-12-19 - Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S7211)
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Allows state Medicaid programs to cover whole genome sequencing services for certain individuals. Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to an intensive care unit or seen by a medical specialist for a suspected genetic or undiagnosed disease, or (2) are suspected by a medical specialist to have a neonatal- or pediatric-onset genetic disease. The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Ending the Diagnostic Odyssey Act of 2019

Sponsors


History

DateChamberAction
2019-12-19SenateRead twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S7211)

Same As/Similar To

HB4144 (Related) 2019-08-05 - Referred to the Subcommittee on Health.
HB4393 (Related) 2019-09-19 - Referred to the Subcommittee on Health.

Subjects


US Congress State Sources


Bill Comments

feedback